Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/24/22
End: 11/11/24
Due: 11/11/25
Phase: N/A
Priority: Normal
Start: 12/21/20
End: 10/27/21
Due: 10/27/22
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Retinal Vein Occlusion | NCT05532735 | Annexin Pharmaceuticals AB | user2@example.com | None | 2022-08-24 | 2024-11-11 | 2025-11-11 | - | - | 2025-07-14 |
| First in Human Study of ANXV (Recombinant Human Annexin A5) in Healthy Volunteers | NCT04850339 | Annexin Pharmaceuticals AB | user2@example.com | None | 2020-12-21 | 2021-10-27 | 2022-10-27 | - | - | 2025-07-14 |